You are viewing: Italy Compounding Pharmacy Market analysis
Part of: Compounding Pharmacy Market (Global)

The Italy Compounding Pharmacy Market was valued at $155.2 Million in 2025 and projected to reach to $211.2 Million by 2030, representing a compound annual growth rate of 6.4%. Italy's compounding pharmacy market is positioned for sustained growth through 2030, supported by regulatory frameworks that encourage specialized pharmaceutical services and rising healthcare provider adoption of personalized medicine approaches.

Italy Compounding Pharmacy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Compounding Pharmacy Market Trends and Insights

  • This growth trajectory reflects Italy's increasing demand for personalized pharmaceutical solutions and regulatory support for specialized compounding services.
  • Italy's healthcare system continues to recognize the clinical and economic value of customized medications, particularly for pediatric, geriatric, and specialty patient populations. The Italian compounding pharmacy sector is driven by rising prevalence of chronic diseases, growing patient preference for tailored dosage forms, and enhanced reimbursement frameworks.
  • Italy's aging demographic and expanding specialty care infrastructure are key catalysts for market expansion through 2030.
  • Regulatory harmonization within the European Union also supports Italy's compounding pharmacy growth, enabling cross-border best practices and standardized quality protocols..

Key Market Statistics

  • CAGR (2025-2030) 6.4% CAGR
  • Market Size, 2025 ~USD 155.2 Million
  • Forecast, 2030 ~USD 211.2 Million
  • Country Italy

Italy Compounding Pharmacy Market Overview

Market Valuation Growth :

Italy's compounding pharmacy market is valued at USD 155.2 million in 2025 and is projected to reach USD 211.2 million by 2030, demonstrating robust expansion driven by personalized medicine adoption.

Strong CAGR Performance :

Italy's market is growing at a CAGR of 6.4% (2025-2030), outpacing the global average of 5.7%, indicating accelerated demand for specialized compounding services within the Italian healthcare ecosystem.

Regulatory Support Framework :

Italy's healthcare system actively supports specialized compounding pharmacy services through favorable regulatory policies, enabling pharmacists to deliver customized pharmaceutical solutions tailored to patient needs.

Personalized Medicine Demand :

Increasing patient preference for personalized pharmaceutical solutions in Italy is driving market expansion, with healthcare providers recognizing the clinical and economic benefits of customized compounding services.

Italy Compounding Pharmacy Market Dynamics

  • The market's 6.4% CAGR reflects growing recognition among Italian patients and clinicians of the therapeutic advantages offered by customized pharmaceutical formulations.
  • Healthcare modernization initiatives and increased investment in specialized pharmacy services are expected to further accelerate market penetration across Italian regions.
  • The convergence of regulatory support, clinical demand, and patient preference for tailored solutions creates a favorable environment for compounding pharmacy expansion throughout the forecast period..

Market Ecosystem

logo-mobile

COMPOUNDING PHARMACY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides sterile and non-sterile compounding services, including ready-to-dispense and ready-to-administer personalized medicines for pharmacies, hospitals, and clinics | Its compounding operations support customized strengths, dosage forms, ingredient requirements, and therapies where commercially available medicines may be unsuitable or unavailable. Enables healthcare providers to address patient-specific medication requirements, drug shortages, discontinued products, allergies, and dosage-form limitations while outsourcing complex sterile and non-sterile compounding activities.
company logo
Operates both a 503A compounding pharmacy for patient-specific prescriptions and an FDA-registered 503B outsourcing facility for office-use medications | Its portfolio includes compounded preparations across multiple therapeutic areas and dosage forms, supported by sterile batch testing and cGMP processes at the 503B facility. Expands access to individualized medicines and multiple strengths and dosage forms while enabling healthcare providers to procure larger-scale compounded products from a regulated outsourcing facility.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Italy's compounding pharmacy market is valued at USD 155.2 million in 2025 and is forecast to reach USD 211.2 million by 2030.
    • Italy is experiencing a 6.4% CAGR, outpacing the global average of 5.7%, driven by personalized medicine adoption.
    • Italy's aging population and chronic disease prevalence are primary growth drivers for customized pharmaceutical solutions.
    • EU regulatory alignment strengthens Italy's compounding pharmacy infrastructure and cross-border operational efficiency.

    Compounding Pharmacy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HORMONE REPLACEMENT THERAPIES (Therapeutic Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.7% from 2025 to 2030
    Largest Segment PHARMACEUTICAL DOSAGE ALTERATION (Compounding Type)
    Market Size Base Year (Billions) ~USD 14.71 (2025)
    Revenue Forecast (Billions) ~USD 19.41 (2030)
    Segments Covered Product, Compounding Type, Therapeutic Application

    Italy Compounding Pharmacy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Nasal Drugs
    • Ophthalmic Drugs
    • Oral Drugs
    • Other Products
    • Parenteral Drugs
    • Rectal Drugs
    • Topical Drugs

    By Compounding Type

    • Currently Unavailable Pharmaceutical Manufacturing
    • Pharmaceutical Dosage Alteration
    • Pharmaceutical Ingredient Alteration

    By Therapeutic Application

    • Dermal Disorders
    • Hormone Replacement Therapies
    • Nutritional Supplements
    • Other Therapeutic Applications
    • Pain Management

    ITALY: COMPOUNDING PHARMACY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ADULTS214.1240.1263.6284.6303319.5337.2356.96.3
    GERIATRIC PATIENTS95.2106115.5123.8130.8136.9143.3150.55.4
    PEDIATRIC PATIENTS64.172.981.188.795.7102.2109.2117.17.6
    TOTAL373.5419460.2497.2529.5558.6589.7624.66.3

    Target Audience

    • Pharmaceutical Manufacturers : Italian and international pharmaceutical companies need Italy-specific market data to identify compounding opportunities, assess competitive positioning, and develop localized product strategies for the Italian market.
    • Pharmacy Operators & Networks : Independent and chain pharmacies in Italy require detailed market insights to evaluate compounding service expansion opportunities, understand demand drivers, and benchmark performance against market growth trends.
    • Healthcare Investors & PE Firms : Investment firms targeting Italian healthcare assets need precise market valuations, growth forecasts, and regulatory insights to evaluate acquisition targets and investment returns in the compounding pharmacy sector.
    • Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors serving Italian clients require country-specific market data to support strategic recommendations, feasibility studies, and business case development for compounding pharmacy initiatives.
    • Government & Regulatory Bodies : Italian healthcare policymakers and regulatory agencies need market intelligence to inform healthcare policy decisions, resource allocation, and regulatory frameworks supporting specialized compounding pharmacy services.

    Key Companies in the Italy Compounding Pharmacy Market

    CompanyHQOwnershipStrongest segments
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FAGRONBelgiumPublic CompanyEssentials (APIs, excipients, bases),Brands (derma, immunology, hair, scar care),Compounding Services,

    BAXTER

    Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates as a major medical device and pharmaceutical manufacturer serving global markets.

    FAGRON

    Fagron is a publicly traded Belgian pharmaceutical company founded in 1990 with 4,880 employees. The company focuses on pharmaceutical compounding and specialty pharmacy solutions.

    Reasons to Buy this Report

    • Market-Specific Sizing Data : Access precise valuation figures for Italy's compounding pharmacy market (USD 155.2M in 2025) with detailed 5-year forecasts, enabling accurate business planning and investment decisions specific to the Italian market.
    • Competitive Intelligence : Understand Italy's unique market dynamics, regulatory environment, and growth drivers that differentiate it from global trends, providing strategic advantages for market entry or expansion within Italian healthcare.
    • Growth Opportunity Assessment : Leverage Italy's above-average 6.4% CAGR to identify high-potential market segments and geographic regions within the country, optimizing resource allocation and revenue projections for Italian operations.
    • Regulatory & Healthcare Insights : Gain detailed understanding of Italy's supportive regulatory framework for compounding pharmacies and healthcare system dynamics, essential for compliance and partnership development with Italian healthcare providers.
    • Strategic Market Positioning : Develop targeted go-to-market strategies for Italy by analyzing personalized medicine adoption trends, patient preferences, and healthcare provider demand patterns specific to the Italian pharmaceutical landscape.

    Frequently asked questions

    What is the current market size of Italy's compounding pharmacy sector?

    Italy's compounding pharmacy market is valued at USD 155.2 million in 2025 and is projected to grow to USD 211.2 million by 2030.

    What is the expected growth rate for Italy's compounding pharmacy market?

    Italy's compounding pharmacy market is expected to grow at a CAGR of 6.4% from 2025 to 2030, exceeding the global average.

    What factors are driving growth in Italy's compounding pharmacy market?

    Key drivers include Italy's aging demographic, rising chronic disease prevalence, increased demand for personalized medications, and supportive EU regulatory frameworks.

    How does Italy's compounding pharmacy growth compare to global trends?

    Italy's 6.4% CAGR outpaces the global compounding pharmacy market CAGR of 5.7%, reflecting stronger regional demand for customized pharmaceutical solutions.

    What patient populations benefit most from compounding pharmacies in Italy?

    Pediatric, geriatric, and specialty care patients in Italy benefit most from compounding pharmacies due to personalized dosage forms and tailored therapeutic solutions.

    RESEARCH METHODOLOGY

    This study involved four major activities to estimate the current size of the compounding pharmacy market. We conducted exhaustive secondary research to gather information on the market, its peer markets, and its parent market. The team then validated these findings, assumptions, and sizing with industry experts across the value chain through primary research. We used both top-down and bottom-up approaches to estimate total market size. We then used data triangulation to estimate market size by segment and subsegment.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), and World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information on major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. We interviewed primary sources from both the supply and demand sides of the market to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Compounding Pharmacy Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    We estimated the global size of the compounding pharmacy market using multiple approaches. We used a detailed market estimation approach to estimate and validate the market value and other dependent submarkets. We also used these methods extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.

    Compounding Pharmacy Market: Top-Down and Bottom-Up Approach

    Compounding Pharmacy Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, we divided the total market into several segments and subsegments. To complete the overall market analysis and obtain precise statistics for all segments and subsegments, we used data triangulation and market breakdown methods where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    A compounding pharmacy is a specialized practice in which a licensed pharmacist combines, mixes, or alters raw drug ingredients to formulate customized medications tailored to individual patients' unique health needs. This process allows pharmacists to create pharmaceutical products in various forms, such as liquids, creams, gels, or capsules, and can be vital for patients with specific allergies, intolerances, or those needing dosages not commercially available. Compounding pharmacists often work closely with healthcare providers to develop formulas that address particular medical conditions, ensuring that each preparation is safe, effective, and personalized to optimize patient care. Additionally, compounding pharmacies adhere to stringent regulatory standards to maintain the integrity and quality of the medications they produce.

    Key Stakeholders

    • Pharmaceutical & Biotechnology Companies
    • Compounding Pharmacies
    • Research & Consulting Firms
    • Academic Medical Centers
    • Government Regulatory & Research Organizations
    • Quality Assurance & Accreditation Bodies
    • Clinical Research Institutes

    Report Objectives

    • To define, describe, and forecast the compounding pharmacy market based on product, compounding type, therapeutic application, sterility, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall compounding pharmacy market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific compounding pharmacy market into countries
    • A further breakdown of the Rest of Europe compounding pharmacy market into countries
    • A further breakdown of the Rest of Latin America compounding pharmacy market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).
     

     

    Get the Full Compounding Pharmacy Market Report

    Full forecast, segment splits, and company analysis for all Compounding Pharmacy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status